Editorial: Novel ideas for accelerators, particle detection and data challenges at future colliders
Frontiers in Physics, 2023 Alessandro Tricoli +3 more
doaj +1 more source
Adaptive control system for collaborative sorting robotic arms based on multimodal sensor fusion and edge computing. [PDF]
Sci RepFeng Y.
europepmc +1 more source
A NEW FORMULA FOR COMPUTING THE SOLAR CONSTANT FROM PYRHELIOMETRIC OBSERVATIONS
, 1908 HERBERT H. KIMBALL
openalex +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Molecular Oncology, EarlyView.Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Discussion: “A Mechanical Analyzer for Computing Transient Stresses in Airplane Structures” (Bisplinghoff, R. L., Pian, T. H. H., and Levy, L. I., 1950, ASME J. Appl. Mech., 17, pp. 310–314) [PDF]
, 1951 Robert H. Scanlan
openalex +3 more sources
Advances of Emerging Memristors for In-Memory Computing Applications. [PDF]
Research (Wash D C)Chen Q, Lu L, Meng J, Xu M, Wang T.
europepmc +1 more source
Department of Applied Statistics (Computing Section), University of London, University College: Tracts for Computers [PDF]
, 1921 openalex +1 more source
Molecular Oncology, EarlyView.A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
Analysis of Deep Reinforcement Learning Algorithms for Task Offloading and Resource Allocation in Fog Computing Environments. [PDF]
Sensors (Basel)Ali EM, Abawajy J, Lemma F, Baho SA.
europepmc +1 more source
Molecular Oncology, EarlyView.This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga +8 more
wiley +1 more source